Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

electroCore Inc

ECOR
16,20
0,30 (1,89%)
Ultimo aggiornamento: 16:56:49
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/1/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202512:30EDGAR2Form 8-K - Current report
07/1/202514:00GLOBEelectroCore Expands Intellectual Property Portfolio
17/12/202423:27EDGAR2Form 8-K - Current report
17/12/202422:05GLOBENeuroMetrix to be Acquired by electroCore
29/11/202422:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/11/202422:01EDGAR2Form 8-K - Current report
20/11/202414:00GLOBEelectroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50..
19/11/202414:00GLOBEelectroCore Donates gammaCore Sapphire for Real World..
15/11/202422:03EDGAR2Form D - Notice of Exempt Offering of Securities
14/11/202414:00GLOBEelectroCore to Participate at the Canaccord Genuity MedTech,..
13/11/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:17EDGAR2Form 8-K - Current report
13/11/202422:01GLOBEelectroCore Announces Third Quarter 2024 Financial Results
12/11/202422:01GLOBEElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech..
08/11/202422:01GLOBEelectroCore Announces Inducement Grant under NASDAQ Listing..
23/10/202414:00GLOBEelectroCore to Announce Third Quarter September 30, 2024..
26/9/202414:00GLOBEelectroCore to Participate in Upcoming Investor Conferences
24/9/202414:00GLOBEelectroCore Engages FNK IR to Execute Expanded Investor..
10/9/202414:00GLOBEStudy Suggests Non-invasive Vagus Nerve Stimulation (nVNS)..
06/9/202423:05EDGAR2Form 8-K - Current report
06/9/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202403:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202414:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202414:00GLOBEelectroCore to Participate in Upcoming Investor Conferences
07/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:11EDGAR2Form 8-K - Current report
07/8/202422:01GLOBEelectroCore Announces Second Quarter 2024 Financial Results
02/8/202422:05GLOBEelectroCore Announces Inducement Grant under NASDAQ Listing..
01/8/202414:00GLOBENon-invasive Vagus Nerve Stimulation (nVNS) is effective at..
31/7/202414:00GLOBEelectroCore to Announce Second Quarter June 30, 2024..
23/7/202418:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/7/202421:40EDGAR2Form S-1/A - General form for registration of securities..
17/7/202423:15EDGAR2Form DEF 14A - Other definitive proxy statements
17/7/202423:06EDGAR2Form 8-K - Current report
10/7/202422:07EDGAR2Form S-1 - General form for registration of securities under..
25/6/202414:00GLOBEelectroCore Announces the Commercial Launch of TAC-STIM™
11/6/202414:00GLOBEelectroCore to Join Russell Microcap® Index
07/6/202422:33EDGAR2Form SC 13D/A - General statement of acquisition of..
07/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202414:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202414:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202414:00GLOBEelectroCore, Inc. Announces Closing of $9.3 Million..
04/6/202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/6/202416:26EDGAR2Form 8-K - Current report
03/6/202414:30GLOBEelectroCore, Inc. Announces $9.3 Million Registered Direct..
29/5/202415:00GLOBEFirefly Neuroscience, an AI-Driven Brain Health Company,..
08/5/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 15,90 Min: 15,35 Max: 16,20
Chiusura: 15,90

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network